Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/10567905

Int. J. Cancer 1999 Dec 22 84 6 598-603

Download in:

View as

General Info

PMID
10567905